PGP and breast carcinoma: Furthermore, this supramolecular hydrogel serves as a simple and effective codelivery platform for DOX, where the released NO can reverse the P-gp-mediated MDR effect, increasing the sensitivity of breast cancer cells to DOX, thereby achieving a synergistic antitumor effect on drug-resistant breast cancer in vivo [123].